These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38967099)

  • 1. Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers.
    Rasch MNB; Szabados F; Jensen JMB; Nielsen KO; Hauge EM; Troldborg A
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 38967099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.
    Himmelmann A; Brücker R
    Eur J Case Rep Intern Med; 2021; 8(4):002484. PubMed ID: 33987129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about
    Mascaro JM; Rodriguez-Pinto I; Poza G; Mensa-Vilaro A; Fernandez-Martin J; Caminal-Montero L; Espinosa G; Hernández-Rodríguez J; Diaz M; Rita-Marques J; Sanmarti R; Castañeda S; Colunga D; Coto-Hernández R; Fanlo P; Elejalde JI; Bujan S; Figueras I; Marco FM; Andrés M; Suárez S; Gonzalez-Garcia A; Fustà-Novell X; Garcia-Belando C; Granados A; Fernandez-Figueras MT; Quilis N; Orriols-Caba M; Gómez de la Torre R; Cid MC; Espígol-Frigolé G; Alvarez-Abella A; Labrador E; Rozman M; Lopez-Guerra M; Castillo P; Alamo-Moreno JR; Gonzalez-Roca E; Plaza S; Fabregat V; Lara R; Vicente-Rabaneda EF; Tejedor-Vaquero S; Magri G; Bonet N; Solis-Moruno M; Cerutti A; Fornas O; Casals F; Yagüe J; Aróstegui JI
    Ann Rheum Dis; 2023 Dec; 82(12):1594-1605. PubMed ID: 37666646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.
    Kreutzinger V; Pankow A; Boyadzhieva Z; Schneider U; Ziegeler K; Stephan LU; Kübke JC; Schröder S; Oberender C; le Coutre P; Stintzing S; Jelas I
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.
    Lecoeuvre H; Le Gall F; Le Naoures C; Vignon-Pennamen MD; Lamaison C; Kammerer-Jacquet SF; Lescoat A; Oger E; Pastoret C; Dupuy A
    Clin Exp Dermatol; 2024 Jul; 49(8):825-833. PubMed ID: 38366665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome.
    Maeda A; Tsuchida N; Uchiyama Y; Horita N; Kobayashi S; Kishimoto M; Kobayashi D; Matsumoto H; Asano T; Migita K; Kato A; Mori I; Morita H; Matsubara A; Marumo Y; Ito Y; Machiyama T; Shirai T; Ishii T; Kishibe M; Yoshida Y; Hirata S; Akao S; Higuchi A; Rokutanda R; Nagahata K; Takahashi H; Katsuo K; Ohtani T; Fujiwara H; Nagano H; Hosokawa T; Ito T; Haji Y; Yamaguchi H; Hagino N; Shimizu T; Koga T; Kawakami A; Kageyama G; Kobayashi H; Aoki A; Mizokami A; Takeuchi Y; Motohashi R; Hagiyama H; Itagane M; Teruya H; Kato T; Miyoshi Y; Kise T; Yokogawa N; Ishida T; Umeda N; Isogai S; Naniwa T; Yamabe T; Uchino K; Kanasugi J; Takami A; Kondo Y; Furuhashi K; Saito K; Ohno S; Kishimoto D; Yamamoto M; Fujita Y; Fujieda Y; Araki S; Tsushima H; Misawa K; Katagiri A; Kobayashi T; Hashimoto K; Sone T; Hidaka Y; Ida H; Nishikomori R; Doi H; Fujimaki K; Akasaka K; Amano M; Matsushima H; Kashino K; Ohnishi H; Miwa Y; Takahashi N; Takase-Minegishi K; Yoshimi R; Kirino Y; Nakajima H; Matsumoto N
    Rheumatology (Oxford); 2024 Aug; 63(8):2056-2064. PubMed ID: 37606963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
    Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
    Front Immunol; 2022; 13():897722. PubMed ID: 35757758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on VEXAS syndrome.
    Al-Hakim A; Savic S
    Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.
    De Santis M; Tonutti A; Motta F; Todisco G; Manes N; Milanesi C; Caselli R; Albertazzi S; Bonometti A; Selmi C; Della Porta MG
    Ann Hematol; 2024 Nov; 103(11):4789-4791. PubMed ID: 39177793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEXAS within the spectrum of rheumatologic disease.
    Koster MJ; Warrington KJ
    Semin Hematol; 2021 Oct; 58(4):218-225. PubMed ID: 34802543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report.
    Fukuda N; Kanai D; Hoshino K; Fukuda Y; Morita R; Ishikawa Y; Kanaoka T; Toya Y; Kirino Y; Wakui H; Tamura K
    BMC Nephrol; 2024 Jan; 25(1):18. PubMed ID: 38212709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
    Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
    Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I diagnose and manage VEXAS syndrome.
    Hagiya A; Siddiqi IN; Wang E; Lu CM
    Am J Clin Pathol; 2024 Jul; 162(1):28-40. PubMed ID: 38511841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEXAS syndrome.
    Nakajima H; Kunimoto H
    Int J Hematol; 2024 May; ():. PubMed ID: 38819628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment.
    Tozaki N; Tawada C; Niwa H; Mizutani Y; Shu E; Kawase A; Miwa Y; Ohnishi H; Sasai H; Miyako K; Hosokawa J; Kato A; Kobayashi K; Miyazaki T; Shirakami Y; Shimizu M; Iwata H
    Front Med (Lausanne); 2022; 9():1046820. PubMed ID: 36544501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
    Patel N; Dulau-Florea A; Calvo KR
    Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.